142 related articles for article (PubMed ID: 15379942)
1. Advances in the management of non-seminomatous germ cell tumors during the cisplatin era: a single-institution experience.
Muramaki M; Hara I; Miyake H; Yamada Y; Kawabata G; Kamidono S
Int J Urol; 2004 Sep; 11(9):768-73. PubMed ID: 15379942
[TBL] [Abstract][Full Text] [Related]
2. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.
Sonneveld DJ; Hoekstra HJ; van der Graaf WT; Sluiter WJ; Mulder NH; Willemse PH; Koops HS; Sleijfer DT
Cancer; 2001 Apr; 91(7):1304-15. PubMed ID: 11283931
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
6. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
Marwaha S; Venner PM; North SA
Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of chemotherapy for advanced testicular and extragonadal germ cell tumors: a single-center 27-year experience.
Tanaka T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T
Jpn J Clin Oncol; 2010 Jan; 40(1):73-8. PubMed ID: 19773268
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of retroperitoneal lymph node dissection after induction chemotherapy for metastatic non-seminomatous germ cell tumors.
Muramaki M; Hara I; Miyake H; Yamada Y; Okada H; Kamidono S
Int J Urol; 2004 Sep; 11(9):763-7. PubMed ID: 15379941
[TBL] [Abstract][Full Text] [Related]
9. [Long-term results of multimodality therapy of testicular germ cell tumor].
Wang JW; Yang L; Wang JY; Qu T; Cai RG; Huang J; Sun Y
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):382-5. PubMed ID: 12921572
[TBL] [Abstract][Full Text] [Related]
10. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
[TBL] [Abstract][Full Text] [Related]
12. First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party.
Rosti G; De Giorgi U; Wandt H; Lioure B; Leyvraz S; Kolbe K; Papiani G; Ballardini M; Kulekci A; Demirer T;
Bone Marrow Transplant; 2004 Dec; 34(12):1033-7. PubMed ID: 15516940
[TBL] [Abstract][Full Text] [Related]
13. [Testicular germ cell tumors: prognosis].
Miladi M; Peyromaure M; Remi J; Beuzeboc P; Debre B; Zerbib M
Prog Urol; 2003 Feb; 13(1):92-7. PubMed ID: 12703360
[TBL] [Abstract][Full Text] [Related]
14. Excellent outcome in patients with stage I germ cell tumors of the testes: a study of the Children's Cancer Group/Pediatric Oncology Group.
Schlatter M; Rescorla F; Giller R; Cushing B; Vinocur C; Colombani P; Cullen J; London W; Davis M; Lauer S; Olson T; ;
J Pediatr Surg; 2003 Mar; 38(3):319-24; discussion 319-24. PubMed ID: 12632342
[TBL] [Abstract][Full Text] [Related]
15. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ
J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162
[TBL] [Abstract][Full Text] [Related]
16. Resection of pulmonary metastases following chemotherapy for high stage testicular tumors.
Eskicorapci SY; Ekici S; Atsu MN; Dogan R; Ozen H
Int J Urol; 2004 Aug; 11(8):634-9. PubMed ID: 15285754
[TBL] [Abstract][Full Text] [Related]
17. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
18. Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis.
van Dijk MR; Steyerberg EW; Habbema JD
Eur J Cancer; 2006 May; 42(7):820-6. PubMed ID: 16574403
[TBL] [Abstract][Full Text] [Related]
19. Mediastinal metastases from testicular nonseminomatous germ cell tumors: patterns of dissemination and predictors of long-term survival with surgery.
Kesler KA; Brooks JA; Rieger KM; Fineberg NS; Einhorn LH; Brown JW
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):913-23. PubMed ID: 12698156
[TBL] [Abstract][Full Text] [Related]
20. Two cycles of cisplatin-based chemotherapy for low-volume retroperitoneal stage II nonseminomatous germ cell tumours.
Steiner H; Müller T; Gozzi C; Akkad T; Bartsch G; Berger AP
BJU Int; 2006 Aug; 98(2):349-52. PubMed ID: 16626306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]